The proposed bill, known as the Defense of Drug Delivery Act, aims to regulate the distribution of drugs under the federal 340B drug pricing program in Kansas. It prohibits manufacturers, third-party logistics providers, and repackagers from denying or restricting the delivery of 340B drugs to covered entities, unless such actions are mandated by federal or state law. Additionally, manufacturers cannot require covered entities to submit health information or other data as a condition for receiving these drugs. The bill establishes a framework for enforcement, allowing the Kansas Attorney General to impose civil penalties for violations and to create a dedicated fund for administering the act.

The bill also includes provisions for the Kansas Board of Pharmacy to investigate complaints related to violations of the act and to impose disciplinary actions on entities found in violation. It clarifies that limited distribution requirements under federal law do not constitute a violation of this act and ensures that the act does not conflict with existing federal laws. The provisions of the act are designed to be severable, meaning that if any part is deemed unconstitutional, the remaining sections will still be enforceable. The act will take effect upon publication in the statute book.